Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor-Reference-Cited by-同舟云学术

Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor

Published:2005-01 Issue:4 Volume:326 Page:744-751
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Soga Takatoshi,Ohishi Takahide,Matsui Tetsuo,Saito Tetsu,Matsumoto Mitsuyuki,Takasaki Jun,Matsumoto Shun-ichiro,Kamohara Masazumi,Hiyama Hideki,Yoshida Shigeru,Momose Kazuhiro,Ueda Yoshitaka,Matsushime Hitoshi,Kobori Masato,Furuichi Kiyoshi

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference36 articles.

1. LPA: a novel lipid mediator with diverse biological actions;Moolenaar;Trends Cell Biol.,1994

2. Atherosclerosis;Lusis;Nature,2000

3. Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines;Murugesan;J. Mol. Cell. Cardiol.,2003

4. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages;Yamamoto;J. Immunol.,1991

5. Autacoid properties of lysophosphatidylserine;Bruni;Prog. Clin. Biol. Res.,1988

Cited by 317 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anandamide: From modulation of neuronal excitation to antimicrobial activities—What is in common?;Anandamide in Health and Disease;2025

2. Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review;Veterinary Research Communications;2024-08-20

3. From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling;Molecules;2024-08-04

4. Receptors and Signaling Pathways Controlling Beta-Cell Function and Survival as Targets for Anti-Diabetic Therapeutic Strategies;Cells;2024-07-24

5. GPR119 agonists for type 2 diabetes: past failures and future hopes for preclinical and early phase candidates;Expert Opinion on Investigational Drugs;2024-02-23